Clinical Trial

Women's Knowledge of Contraception During the Postpartum Period

Study acronym: CO CT-PP
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
In France, the number of unintended or unwanted pregnancies remains a public health issue, often leading to voluntary termination of pregnancy. This issue is, moreover, one of the priorities of the national sexual health strategy launched by the Ministry of Social Affairs and Health for the period from 2017 to 2030. The postpartum period (ranging from 0 to 24 months) is recognized as a high-risk period for unplanned pregnancies, which may result in voluntary termination of pregnancy. This observation raises questions about the effectiveness of prevention and information policies regarding postpartum fertility and the various contraceptive methods. Better information and the use of regular contraception, or recourse to emergency contraception, could help reduce the number of unwanted pregnancies during the postpartum period.
Trial Details
NCT Number NCT07437495
Lead Sponsor Université de Reims Champagne-Ardenne
Conditions Contraception
Enrollment 1,000 participants
Start Date 2025-12-18
Primary Completion 2025-12-18 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-27